Immune Response Modulation by HPV16 Oncoproteins in Lung Cancer: Insights from Clinical and In Vitro Investigations
Viruses · 2024
DOI: 10.3390/v16111731 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Bianca de França São Marcos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Av. Prof. Moraes Rego, 1235, Cida…. Hauptthemen laut MEDLINE: Lung Neoplasms, Oncogene Proteins, Viral, Human papillomavirus 16, Papillomavirus Infections. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPQ)/Departamento de Ciência e Tecnologia da Secretaria de Ciência, Tecnologia, Inovação e Comp…, CNPq/MS.
Abstract (Originalsprache)
Lung cancer has the highest mortality rates worldwide, and Human Papillomavirus (HPV) has been associated with its carcinogenesis. In this study, HPV16 genes’ expressions were investigated in patient samples, along with the immunological response promoted by lymphocytes and monocytes in A549 cells transfected with HPV oncogenes and co-cultured with PBMC. An increase in the expression of E5 was observed in the patients’ samples. In the in vitro analysis, a decrease in the number of monocytes and cytotoxic cells was observed when co-stimulated by E6 and E7, and it promoted an increase in the Th2 profile. In contrast, the high proliferation of cytotoxic cells in A549 cells transfected with E5, associated with the high expression of costimulatory molecules in monocytes, suggests a low capacity of E5 to inhibit the presentation of antigens by antigen-presenting cells (APC) and a possible use of E5 in future therapeutic strategies against lung cancers associated with HPV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Av. Prof. Moraes Rego, 1235, Cidade Universitária Recife, Recife 50670-901, PE, Brazil.
- Keizo Asami Immunopathology Laboratory, Federal University of Pernambuco, Av. Prof. Moraes Rego, 1235, Cidade Universitária Recife, Recife 50670-901, PE, Brazil.
- Immunological and Antitumor Analysis Laboratory, Department of Antibiotics, Federal University of Pernambuco, Recife 50670-901, PE, Brazil.
- Patrick G Jonhston Centre for Cancer Research, Queen's University Belfast, Belfast BT7 1NN, UK.
ORCID-Profile: Georon Ferreira de Sousa, Talita Helena de Araújo Oliveira, Antonio Carlos de Freitas
Förderung
- National Council for Scientific and Technological Development
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPQ)/Departamento de Ciência e Tecnologia da Secretaria de Ciência, Tecnologia, Inovação e Comp…
- CNPq/MS
- CNPq Bolsa Produtividade
- Bolsa Produtividade
Zitieren
APA
São Marcos, B. F., Santos, D. L. D., Sousa, G. F., Cruz, L. C. O., Barros, B. R. D. S., de Sena, M. G. A. M., Santos, V. E. P., Oliveira, T. H. A., Lagos de Melo, C. M., & de Freitas, A. C. (2024). Immune Response Modulation by HPV16 Oncoproteins in Lung Cancer: Insights from Clinical and In Vitro Investigations. Viruses. https://doi.org/10.3390/v16111731
Vancouver
São Marcos BF, Santos DLD, Sousa GF, Cruz LCO, Barros BRDS, de Sena MGAM, et al. Immune Response Modulation by HPV16 Oncoproteins in Lung Cancer: Insights from Clinical and In Vitro Investigations. Viruses. 2024. doi:10.3390/v16111731
BibTeX
@article{SoMarcos2024,
author = {São Marcos, Bianca de França and Santos, Daffany Luana Dos and Sousa, Georon Ferreira de and Cruz, Leonardo Carvalho de Oliveira and Barros, Bárbara Rafaela da Silva and de Sena, Matheus Gardini Amâncio Marques and Santos, Vanessa Emanuelle Pereira and Oliveira, Talita Helena de Araújo and Lagos de Melo, Cristiane Moutinho and de Freitas, Antonio Carlos},
title = {Immune Response Modulation by HPV16 Oncoproteins in Lung Cancer: Insights from Clinical and In Vitro Investigations},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16111731}
}
EUVIMED